Connexin37-Dependent Mechanisms Selectively Contribute to Modulate Angiotensin II -Mediated Hypertension

J Am Heart Assoc. 2019 Apr 16;8(8):e010823. doi: 10.1161/JAHA.118.010823.

Abstract

Background Gap junction channels made of Connexin37 (Cx37) are expressed by aortic endothelial and smooth muscle cells of hypertensive mice, as well as by the renin-secreting cells of kidneys. Methods and Results To decipher whether Cx37 has any role in hypertension, angiotensin II (Ang II ) was infused in normotensive wild-type and Cx37-deficient mice (Cx37-/-). After 2 to 4 weeks, the resulting increase in blood pressure was lower in Cx37-/- than in wild-type mice, suggesting an alteration in the Ang II response. To investigate this possibility, mice were submitted to a 2-kidney, 1-clip procedure, a renin-dependent model of hypertension. Two weeks after this clipping, Cx37-/- mice were less hypertensive than wild-type mice and, 2 weeks later, their blood pressure had returned to control values, in spite of abnormally high plasma renin levels. In contrast, Cx37-/- and wild-type mice that received N-nitro-l-arginine-methyl-ester, a renin-independent model of hypertension, featured a similar and sustained increase in blood pressure. The data indicate that loss of Cx37 selectively altered the Ang II -dependent pathways. Consistent with this conclusion, aortas of Cx37-/- mice featured an increased basal expression of the Ang II type 2 receptors ( AT 2R), and increased transcripts levels of downstream signaling proteins, such as Cnksr1 and Ptpn6 ( SHP -1). Accordingly, the response of Cx37-/- mice aortas to an ex vivo Ang II exposure was altered, since phosphorylation levels of several proteins of the Ang II pathway ( MLC 2, ERK , and AKT ) remained unchanged. Conclusions These findings provide evidence that Cx37 selectively influences Ang II signaling, mostly via a modulation of the expression of the Ang II type 2 receptor.

Keywords: angiotensin II; aorta; connexins; endothelial cells; hypertension; kidney; smooth muscle cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin II / pharmacology
  • Animals
  • Aorta / cytology
  • Aorta / drug effects
  • Aorta / metabolism*
  • Blood Pressure / drug effects
  • Blood Pressure / genetics*
  • Connexins / genetics*
  • Disease Models, Animal
  • Endothelial Cells / metabolism
  • Enzyme Inhibitors / pharmacology
  • Extracellular Signal-Regulated MAP Kinases / metabolism
  • Gap Junction alpha-4 Protein
  • Hypertension / genetics*
  • Hypertension / metabolism
  • Male
  • Mice
  • Mice, Knockout
  • Muscle, Smooth, Vascular / cytology
  • Myocytes, Smooth Muscle / metabolism
  • Myosin Light Chains / metabolism
  • NG-Nitroarginine Methyl Ester / pharmacology
  • Protein Tyrosine Phosphatase, Non-Receptor Type 6 / genetics
  • Proto-Oncogene Proteins c-akt / metabolism
  • Receptor, Angiotensin, Type 2 / metabolism*
  • Renin / metabolism*
  • Vasoconstrictor Agents / pharmacology

Substances

  • Connexins
  • Enzyme Inhibitors
  • Mylpf protein, mouse
  • Myosin Light Chains
  • Receptor, Angiotensin, Type 2
  • Vasoconstrictor Agents
  • Angiotensin II
  • Proto-Oncogene Proteins c-akt
  • Extracellular Signal-Regulated MAP Kinases
  • Protein Tyrosine Phosphatase, Non-Receptor Type 6
  • Ptpn6 protein, mouse
  • Renin
  • NG-Nitroarginine Methyl Ester